ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

Seven New Initiatives For NIH Common Fund

February 26, 2010

Colorado Researchers Study Massage To Reduce Symptoms

September 26, 2003

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997